Company Profile
Incept BioSystems
Reproductive
Gene/Cell Therapy
401 W Morgan Rd
Ann Arbor, MI 48108
USA
www.inceptbio.com
|
Incorporated in 2005
7 Employees
|
Privately Held
|
|
This Year's Highlights
- Incept hired Doug Powers, Ph.D., and CSO of the largest fertility clinic in the U.S. for the past 20 years, as the Company's new V.P. of Scientific and Clinical Development.
- Incept closed a $3.25MM Series A Financing in March, 2007 lead by Venture Investors of Wisconsin.
- In early 2007, a key product development and research relationship was established with Boston IVF to advance early market prototypes and conduct the first human clinical trials.
|
Anticipated Highlights
- First human clinical trial data available in late 2007.
- Manufacturing of consumable, precision device components confirmed by multiple vendors.
- Limited beta launch of product in late 2008.
|
|
Corporate Mission
Incept BioSystems develops innovative microscale technologies that provide fertility specialists breakthrough capabilities to treat infertility. Our technologies improve the in vitro manipulation, performance, and viability of high-value cells, and our mission is to set the standard for next-generation clinical devices for the Assisted Reproduction Technology (ART) laboratory.
|
